Trial intelligence / Profile preview

Sitagliptin vs Sulphonylurea in Muslim T2D Patients During Ramadan

NCT00766441Phase 4Terminated

Sponsor
The University of Manchester
Start
Aug 2008
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by The University of Manchester. Started Aug 2008; status: terminated.

02

Drugs

sitagliptin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00766441.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00766441.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call